ORIGINAL ARTICLE Elaine Symanski á Enrico Bergamaschi á Antonio Mutti Inter- and intra-individual sources of variation in levels of urinary styrene metabolites Received: 10 July 2000 /Accepted: 28 December 2000 Abstract Objective: Given the paucity of studies that have examined variability in biological measures of ex- posure to workplace contaminants, we quanti®ed the intra- and inter-individual sources of variation in uri- nary levels of mandelic acid MA) and phenylglyoxylic acid PGA) among workers exposed to styrene. A sec- ondary objective was to examine eects of job task and the timing of sampling during the workweek on the variation in workers' urinary styrene metabolite levels. Methods: As part of routine biological monitoring, a total of 1,714 measurements of MA and PGA collected from 331 workers between 1985 and 1999 from eight reinforced-plastics plants were abstracted from labora- tory reports. To evaluate sources of variation in levels of urinary styrene metabolites, we applied random-eects models. The in¯uence of job task and day of sampling on metabolite levels was examined using mixed-eects models. Results: PGA levels were characterized by less variation than levels of MA, as were metabolite levels expressed in terms of urinary creatinine concentration. The relative magnitude of the inter-individual to the intra-individual source of variation was generally higher for post-shift urine samples than for pre-shift urine samples. As expected, urinary metabolite levels were highest for laminators and for samples collected at the latter end of the workweek. Owing to the eects of variation from day-to-day, estimates of workers' expo- sures that rely on single measurements would generally perform poorly in a regression analysis designed to ex- amine eects resulting from chronic exposure. However, the bias in an observed slope coecient would be diminished if a second or third urine sample were collected. Conclusions: Quanti®cation of the intra- and inter-individual sources of variation provides useful information that can be used to design optimal sampling strategies, which would allow for the collection of sucient data to estimate workers' exposures reliably when evaluating health risks associated with occupa- tional contaminants. Key words Exposure assessment á Styrene á Mandelic acid á Phenylglyoxylic acid á Biological monitoring Introduction Styrene is an important chemical used in a broad range of industrial applications including the manufacture of plastics, synthetic rubbers, and resins. Airborne levels of styrene are generally low in most industrial settings ex- cept for the reinforced-plastics industry World Health Organization 1983; IARC 1994), which uses styrene as a solvent for unsaturated resin and as a reactant for po- lymerization during the production of boats, tanks, and other reinforced-plastics products. The main route of uptake of styrene is through inhalation; studies suggest that percutaneous absorption contributes negligible amounts to total exposure in the reinforced-plastics industry Sorsa et al. 1991; Limasset et al. 1999). Ap- proximately 60 to 70% of the inhaled styrene is retained in the body and is readily distributed to the blood and fat tissues Bond 1989; Sumner and Fennell 1994). The major metabolic pathway involves the oxidation of sty- rene to styrene-7,8-oxide by hepatic cytochrome P-450 isozymes. Styrene oxide is hydrolyzed to styrene glycol, which is subsequently oxidized into mandelic acid MA) and further to phenylglyoxylic acid PGA). Excretion of MA appears to be biphasic, with half-times that have been reported to range from 4 to 9 h for the fast elimi- nation phase and 17 to 25 h for the slow elimination phase Bond 1989). Although there is some indication Int Arch Occup Environ Health 2001) 74: 336±344 Ó Springer-Verlag 2001 E. Symanski &) University of Texas School of Public Health, 1200 Herman Pressler Street, Houston, TX 77030, USA e-mail: esymanski @sph.uth.tmc.edu Tel.: +1-713-500-9238; Fax: +1-713-500-9249 E. Bergamaschi á A. Mutti Laboratory of Industrial Toxicology, Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma Medical School, Parma, Italy